Explore more publications!
Healthy Living Washington
Got News to Share?

Healthy Living Washington: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Washington.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 19, 2025

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
December 19, 2025

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

Indeterminate GlobeNewswire
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC
December 19, 2025

Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC

Indeterminate GlobeNewswire
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 19, 2025

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Nyxoah Annonce L’Émission de la Première Tranche des Obligations Convertibles
December 19, 2025

Nyxoah Annonce L’Émission de la Première Tranche des Obligations Convertibles

Indeterminate GlobeNewswire
Lifeward Appoints Bob Marshall as Chairman of the Board
December 19, 2025

Lifeward Appoints Bob Marshall as Chairman of the Board

Indeterminate GlobeNewswire
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
December 19, 2025

NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis

Indeterminate GlobeNewswire
Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)
December 19, 2025

Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)

Indeterminate GlobeNewswire
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
December 19, 2025

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Indeterminate GlobeNewswire
Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
December 19, 2025

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

Indeterminate GlobeNewswire
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
December 19, 2025

U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults

Indeterminate GlobeNewswire
Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care
December 19, 2025

Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care

Indeterminate GlobeNewswire
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
December 19, 2025

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation

Indeterminate GlobeNewswire
Communiqué de presse : Sanofi conclut un accord avec le gouvernement américain pour réduire le coût des médicaments et renforcer l’innovation
December 19, 2025

Communiqué de presse : Sanofi conclut un accord avec le gouvernement américain pour réduire le coût des médicaments et renforcer l’innovation

Indeterminate GlobeNewswire
Tevogen CEO Donates Personal Shares to Support Local Fire Department
December 19, 2025

Tevogen CEO Donates Personal Shares to Support Local Fire Department

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
December 19, 2025

Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman

Indeterminate GlobeNewswire
OncoInv y MaxBloch se asocian para ampliar la detección temprana de cáncer en Centroamérica
December 19, 2025

OncoInv y MaxBloch se asocian para ampliar la detección temprana de cáncer en Centroamérica

Indeterminate GlobeNewswire
OncoInv e MaxBloch firmam parceria para expandir a detecção precoce do câncer em toda a América Central
December 19, 2025

OncoInv e MaxBloch firmam parceria para expandir a detecção precoce do câncer em toda a América Central

Indeterminate GlobeNewswire
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
December 19, 2025

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

Indeterminate GlobeNewswire
NRPA Releases 2025 Engagement With Parks Report Highlighting Continued Public Demand
December 19, 2025

NRPA Releases 2025 Engagement With Parks Report Highlighting Continued Public Demand

Indeterminate GlobeNewswire
Cannabix Technologies Launches New Marijuana Breath Test Product Videos as U.S. Cannabis Reclassification Underscores the Urgent Need for Innovative Public Safety Solutions
December 19, 2025

Cannabix Technologies Launches New Marijuana Breath Test Product Videos as U.S. Cannabis Reclassification Underscores the Urgent Need for Innovative Public Safety Solutions

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions